A double blind, randomized, placebo controlled Clinical Study to Evaluate the efficacy of Menoveda Akira tablet in patients having menopause related mental health issues.

Menoveda Lifesciences Pvt Ltd0 个研究点目标入组 60 人开始时间: 待定最近更新: 2023年5月1日

试验速览

暂无简介。

•1.Females from 45 to 70 years of age, post Menopause.
•2.Females suffering from one or multiple mental health issues from- anxiety, insomnia, depression etc;
•3.Females that are able to give written informed consent in a manner approved by the institutional ethics committee and comply with the requirements of the study.
•4.Females willing to avoid participation in any other interventional clinical trial for the duration of the study.

•1.Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including oral or parenteral corticosteroids.
•2.Females that have participated in any other interventional clinical trial in the previous 30 days.
•3.Females with known sensitivity to any of the constituents of the investigational product.

发起方

Menoveda Lifesciences Pvt Ltd